We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EYEN market cap is 29.23M. The company's latest EPS is USD -0.6179 and P/E is -1.02.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 1,000 | 3k |
| Operating Income | -5.37M | -5.46M | -5.96M | -6.52M | -7.47M |
| Net Income | -6.12M | -5.74M | -6.22M | -7.34M | -7.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 2M | 14M | 0 | 4k |
| Operating Income | -21.31M | -19.79M | -12.9M | -26.91M | -25.41M |
| Net Income | -21.16M | -19.77M | -12.78M | -28.01M | -27.26M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.04M | 29.31M | 29.35M | 34.87M | 28.78M |
| Total Liabilities | 13.8M | 13.5M | 18.83M | 19.09M | 19.78M |
| Total Equity | 17.23M | 15.81M | 10.52M | 15.78M | 9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.7M | 33.91M | 31.66M | 31.04M | 28.78M |
| Total Liabilities | 2.96M | 18.6M | 11.19M | 13.8M | 19.78M |
| Total Equity | 11.74M | 15.3M | 20.47M | 17.23M | 9M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -25.11M | -6.96M | -11.67M | -17.51M | -23.84M |
| Investing | -875k | -838k | -2.12M | -3.83M | -3.97M |
| Financing | 21.51M | 3.4M | 8.4M | 19.18M | 19.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.92M | -6.39M | -20.87M | -25.11M | -23.84M |
| Investing | -167k | -261k | -1.62M | -875k | -3.97M |
| Financing | 13.51M | 20.87M | 21.46M | 21.51M | 19.79M |
| Market Cap | 29.23M |
| Price to Earnings Ratio | -1.02 |
| Price to Sales Ratio | 6.3k |
| Price to Cash Ratio | 1.87 |
| Price to Book Ratio | 3.09 |
| Dividend Yield | - |
| Shares Outstanding | 44.12M |
| Average Volume (1 week) | 502.68k |
| Average Volume (1 Month) | 516.46k |
| 52 Week Change | -77.00% |
| 52 Week High | 2.97 |
| 52 Week Low | 0.501 |
| Spread (Intraday) | 0.27 (34.19%) |
| Company Name | Eyenovia Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.eyenoviabio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
